Immobazyme Secures Investment For Major Expansion
Immobazyme Secures Investment For Major Expansion. Immobazyme is happy to share that it has successfully secured its next round of funding, bringing its total investment raised to date to R24.5 million. This will directly support the company’s expansion, doubling the size of its facility and rapidly scaling up its production capabilities.
“We’re incredibly grateful to all our investors and partners for recognising the value and impact of our work. 💡Daniel S., Wayne Stocks, and the rest of the team at The University Technology Fund (UTF), having you in our corner has been paramount to our success. A big thank you to the team at Innovus Technology Transfer Office at Stellenbosch University (USE); we appreciate all the long hours and hard work it took to bring this deal to closure.” the company said.
Immobazyme is a South African biotechnology spin-out company of Stellenbosch University that utilizes precision fermentation to produce high-value active protein ingredients. The company’s mission is to catalyze the future of global innovation with precision fermentation. By creating the most desirable and accessible recombinant proteins we aim to enable businesses to perfect their products and unlock the full potential of their process.
The company continued to say, “Of course, a special shoutout to our three founders and fearless leaders—Dominic Nicholas, Ethan Hunter, and Nick Enslin. Your relentless drive and leadership have propelled Immobazyme to this major milestone, and you continue to inspire us all!And lastly, thank you to everyone who has been part of this journey. The best is yet to come! 🚀”
